This study is not accepting new patients
Expanded Access for Cancer Treatment With Balstilimab (AGEN2034) and Zalifrelimab (AGEN1884)
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study started
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- not accepting new patients
- Start Date
- Sponsor
- Agenus Inc.
- ID
- NCT05572970
- Study Type
- Expanded Access
- Last Updated